image
Ascendis Pharma A/S ASND
Healthcare - Biotechnology - NASDAQ - DK
Watchlist
$ 156.58
2.25 %
$ 9.37 B
Market Cap
-22.86
P/E
BALANCE SHEET
1.18 B ASSETS
42.87%
Growth Rates
1Year 42.87%
3Years 2.83%
5Years 11.75%
7Years 27.87%
10Years 35.00%
1.29 B LIABILITIES
32.32%
Growth Rates
1Year 32.32%
3Years 85.52%
5Years 74.42%
7Years 76.84%
10Years 58.48%
-106 M EQUITY
27.45%
Growth Rates
1Year 27.45%
3Years -3.84%
5Years -3.31%
7Years -6.60%
10Years -12.71%
BALANCE SHEET DECOMPOSITION
Balance Sheet Ascendis Pharma A/S
image
Current Assets 1.06 B
Cash & Short-Term Investments 560 M
Receivables 177 M
Other Current Assets 324 M
Non-Current Assets 119 M
Long-Term Investments 13.6 M
PP&E 98.7 M
Other Non-Current Assets 6.34 M
Current Liabilities 908 M
Accounts Payable 96.4 M
Short-Term Debt 492 M
Other Current Liabilities 320 M
Non-Current Liabilities 377 M
Long-Term Debt 365 M
Other Non-Current Liabilities 12.3 M

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 559.5 392.2 444.8 446.3 584.5 598.1 277.9 195.4 180.3 119.6 50.2 19.4 14.5 15.7
Short Term Investments 0 7.3 290.7 235.8 134.3 0 0 0 0 0 0 0 0 0
Receivables 177.4 55.8 11.9 2.2 0.4 0.8 2.6 2.4 0.3 1.1 1.3 1.7 6.1 2.0
Inventory 295.6 208.9 130.7 75.4 1 3 1 1 1 1 1 0 0 0
Other Current Assets 28.3 38.6 45.4 46.2 14.0 7.6 12.4 6.9 2.0 3.8 0.6 64 K 90 K 0.3
Total Current Assets 1 060.9 702.7 923.5 805.9 740.1 611.2 292.9 204.6 184.0 125.7 53.2 21.2 20.7 18.0
PP&E 98.7 110.6 129.1 126.0 108.1 45.1 4.3 2.6 2.4 2.4 1.9 2.0 1.2 1.3
Intangible Assets 0.5 0.9 1.3 1.8 2.2 0 0 3.5 0 3.5 3.5 0 0 0
Goodwill 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5
Long Term Investments 13.6 5.7 30.4 145.9 124.5 15.5 17.1 0 0 0 0 0 0 0
Other Long Term Assets 2.3 2.1 1.9 1.8 1.4 1.5 1.2 0.3 0.3 0.3 0.1 33 K 31 K 32 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 1 179.5 825.6 1 089.7 1 084.9 979.8 676.7 319.0 211.0 190.1 131.8 58.7 26.7 25.4 22.8
LIABILITIES
Accounts Payable 96.4 94.6 101.0 59.4 21.9 27.8 19.7 17.4 13.1 8.4 5.0 2.5 2.5 2.5
Short Term Debt 491.5 25.4 25.4 14.0 6.9 5.9 0 0 0 0 0 0 0.2 0.2
Other Current Liabilities 317.8 73.9 39.3 26.8 23.7 14.2 19.2 6.3 94 K 0 0 17.5 0 0
Total Current Liabilities 907.9 197.3 171.3 100.4 52.8 48.0 38.9 23.8 13.5 11.4 12.9 20.4 23.8 22.4
Long Term Debt 365.1 618.9 483.0 98.0 85.1 30.7 0 0 0 0 0 0 0 0.2
Deferred Tax Income 7.3 0 0 (3.0) 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 155.1 172.2 3.0 3.2 0.9 0 0 0 0 0 0 0 0
Total Liabilities 1 285.2 971.3 826.4 201.3 141.1 79.6 38.9 23.8 13.5 11.4 12.9 20.4 23.8 22.6
EQUITY
Common Stock 8.1 7.7 7.7 7.6 7.2 6.4 5.7 5.0 4.4 3.4 2.3 1.4 1.4 1.4
Retained Earnings 0 (2 277.1) (1 855.3) (1 414.6) (1 030.3) (611.3) (393.3) (263.2) 159.3 111.3 39.6 2.1 (1.9) (3.2)
Other Accumulative Comprehensive Income/Loss 0 (153.4) 255.7 876.0 831.5 590.7 274.4 182.2 13.0 5.7 4.0 2.7 2.1 2.0
Total Equity (105.7) (145.7) 263.3 883.6 838.7 597.1 280.1 187.2 176.6 120.3 45.8 6.3 1.6 0.2
Total Liabilities and Equity 1 179.5 825.6 1 089.7 1 084.9 979.8 676.7 319.0 211.0 190.1 131.8 58.7 26.7 25.4 22.8
SHARES OUTSTANDING
Common Shares Outstanding 57.3 56.3 56.1 54.8 50.6 46.5 41.1 33.6 26.6 23.7 16.9 10.8 10.8